APA (7th ed.) Citation

Diacon, A. H., Donald, P. R., Pym, A., Grobusch, M., Patientia, R. F., Mahanyele, R., . . . McNeeley, D. F. (2012). Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance. Antimicrobial Agents and Chemotherapy, 56(6), 3271-3276. https://doi.org/10.1128/AAC.06126-11

Chicago Style (17th ed.) Citation

Diacon, A. H., et al. "Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance." Antimicrobial Agents and Chemotherapy 56, no. 6 (2012): 3271-3276. https://doi.org/10.1128/AAC.06126-11.

MLA (9th ed.) Citation

Diacon, A. H., et al. "Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance." Antimicrobial Agents and Chemotherapy, vol. 56, no. 6, 2012, pp. 3271-3276, https://doi.org/10.1128/AAC.06126-11.